• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. - CRM FACILITY REPLY; PULSE GENERATOR, PERMANENT, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. - CRM FACILITY REPLY; PULSE GENERATOR, PERMANENT, IMPLANTABLE Back to Search Results
Model Number ESPRIT S
Device Problem Loss of Threshold (1633)
Patient Problem Bradycardia (1751)
Event Date 06/16/2015
Event Type  malfunction  
Event Description
Reportedly, the patient went to the emergency room on (b)(6) 2015 presenting bradycardia and asystolic periods (ecg showed ventricular capture loss).A pacemaker follow-up was performed.An alert was displayed in overview showing a lead impedance above 3000 ohms.The physician tested the lead impedance manually and the value remained above 3000 ohms.The ventricular threshold was tested and no capture was possible to achieve, even with 7,5v@1.00ms.In the previous follow-ups the impedance was around 500 ohms, sensing above 15mv and the threshold was stable at 0,75v.On the (b)(6) 2015, the patient went to a re-intervention and the ventricular lead was tested using a psa.The measurements with the psa were unstable.The subject lead was extracted and a new lead (non-sorin) was implanted.Since it was very difficult to remove the entire lead body (adherence to the veins) the proximal lead body was cut and collected to vigilance.After implanting the new lead, the connection between the lead and the can was also unstable (intermittent pacing).The physician decided to replace the device.The subject device will be returned for analysis.
 
Manufacturer Narrative
The device model involved in this mdr report is not approved in the u.S.; however, it is similar to reply dr or sr models approved under p950029.
 
Event Description
Reportedly, the patient went to the emergency room on (b)(6) 2015 presenting bradycardia and asystolic periods (ecg showed ventricular capture loss).A pacemaker follow-up was performed.An alert was displayed in overview showing a lead impedance above 3000 ohms.The physician tested the lead impedance manually and the value remained above 3000 ohms.The ventricular threshold was tested and no capture was possible to achieve, even with 7,5v@1.00ms.In the previous follow-ups the impedance was around 500 ohms, sensing above 15mv and the threshold was stable at 0,75v.On the (b)(6) 2015 the patient went to a re-intervention and the ventricular lead was tested using a psa.The measurements with the psa were unstable.The subject lead was extracted and a new lead (non-sorin) was implanted.Since it was very difficult to remove the entire lead body (adherence to the veins) the proximal lead body was cut and collected to vigilance.After implanting the new lead, the connection between the lead and the can was also unstable (intermittent pacing).The physician decided to replace the device.The subject device will be returned for analysis.
 
Manufacturer Narrative
Preliminary analysis of the returned device did not reveal any anomaly.
 
Event Description
Reportedly, the patient went to the emergency room on (b)(6) 2015 presenting bradycardia and assistolic periods (ecg showed ventricular capture loss).A pacemaker follow-up was performed.An alert was displayed in overview showing a lead impedance above 3000 ohms.The physician tested the lead impedance manually and the value remained above 3000 ohms.The ventricular threshold was tested and no capture was possible to achieve, even with 7,5v@1.00ms.In the previous follow-ups the impedance was around 500 ohms, sensing above 15mv and the threshold was stable at 0,75v.On the (b)(6) 2015 the patient went to a re-intervention and the ventricular lead was tested using a psa.The measurements with the psa were unstable.The subject lead was extracted and a new lead (non-sorin) was implanted.Since it was very difficult to remove the entire lead body (adherence to the veins) the proximal lead body was cut and collected to vigilance.After implanting the new lead, the connection between the lead and the can was also unstable (intermittent pacing).The physician decided to replace the device.The subject device will be returned for analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REPLY
Type of Device
PULSE GENERATOR, PERMANENT, IMPLANTABLE
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L. - CRM FACILITY
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR  92140
Manufacturer (Section G)
SORIN GROUP ITALIA SRL VIA CRESCENTINO 13040 SALUGGIA ITALY
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR   92140
Manufacturer Contact
elodie vincent
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR   92140
0146013665
MDR Report Key4918920
MDR Text Key19004057
Report Number1000165971-2015-00430
Device Sequence Number1
Product Code NVZ
Combination Product (y/n)N
Reporter Country CodePO
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Invalid Data,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 06/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/22/2012
Device Model NumberESPRIT S
Device Catalogue NumberESPRIT S
Device Lot Number2501
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/02/2015
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date06/17/2015
Date Manufacturer Received09/25/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/22/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-